Mass Drug Administration Works, But Programs Must Address Root Causes Of NTDs

In the New York Times’ “Opinionator” blog, Jason Silverstein, a PhD candidate in anthropology at Harvard University, writes about mass drug administration (MDA), a prevention strategy that “has all but eliminated river blindness in the Americas, a disease that had put half a million people at risk of going blind,” noting, “Researchers consider it a key strategy for eliminating other neglected tropical diseases [NTDs].” He discusses MDA’s success against lymphatic filariasis, how programs work, which drugs they choose, their expense, and the importance of community health workers and surveillance. “Despite the success stories, mass drug administration is not enough. If we want to eradicate the world’s neglected diseases, we’ll need to change the environment that allows them to thrive,” such as poor water and sanitation, he concludes (11/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.